Assembly Biosciences (ASMB) EBITDA Margin Growth (1y) (2018 - 2026)
Assembly Biosciences (ASMB) EBITDA Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Assembly Biosciences |
418.96 Mn |
192.36 Mn |
- |
-2,046.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-2,046.00 |
| Dec 31, 2025 |
19,336.00 |
| Sep 30, 2025 |
5,495.00 |
| Jun 30, 2025 |
2,511.00 |
| Mar 31, 2025 |
6,557.00 |
| Dec 31, 2024 |
910.00 |
| Sep 30, 2021 |
-29,046.00 |
| Dec 31, 2020 |
-324,389.00 |
| Sep 30, 2020 |
58,075.00 |
| Jun 30, 2020 |
61,800.00 |
| Mar 31, 2020 |
4,321.00 |
| Dec 31, 2019 |
13,214.00 |
| Sep 30, 2019 |
-8,913.00 |
| Jun 30, 2019 |
23,124.00 |
| Mar 31, 2019 |
-23,587.00 |
| Dec 31, 2018 |
-60,939.00 |
| Sep 30, 2018 |
-4,107.00 |
| Jun 30, 2018 |
-25,919.00 |
| Mar 31, 2018 |
156,784.00 |
